SG
BCDA icon

StoneX Group’s BioCardia BCDA Stock Holding History

StoneX Group’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.8K Buy
+20,020
New +$21.1K ﹤0.01% 1293

Other funds holding BCDA

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PP
Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

StoneX Group's BCDA Position: Q2 2026 in Review

StoneX Group opened a new position in BioCardia (BCDA) in Q2 2026: 20,020 shares worth $24.8K. The stake represents ﹤0.01% of the portfolio and ranks #1293 among its holdings.

21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

  • StoneX Group held 20,020 shares of BioCardia worth $24.8K as of Q2 2026.
  • BioCardia was a new StoneX Group position in Q2 2026.
  • BioCardia made up ﹤0.01% of StoneX Group's portfolio in Q2 2026, its #1293 holding.
  • 21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.